April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Retinal Functional Imaging of Peri-Foveal Blood Flow Velocities in Diabetic Retinopathy
Author Affiliations & Notes
  • K. Mukkamala
    Department of Ophthalmology, The New York Eye and Ear Infirmary, New York, New York
  • L. Spielberg
    Department of Ophthalmology, The New York Eye and Ear Infirmary, New York, New York
  • G. Landa
    Department of Ophthalmology, The New York Eye and Ear Infirmary, New York, New York
  • S. Balasubramanian
    Department of Ophthalmology, The New York Eye and Ear Infirmary, New York, New York
  • R. B. Rosen
    Department of Ophthalmology, The New York Eye and Ear Infirmary, New York, New York
  • Footnotes
    Commercial Relationships  K. Mukkamala, None; L. Spielberg, None; G. Landa, None; S. Balasubramanian, None; R.B. Rosen, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 1055. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Mukkamala, L. Spielberg, G. Landa, S. Balasubramanian, R. B. Rosen; Retinal Functional Imaging of Peri-Foveal Blood Flow Velocities in Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2010;51(13):1055.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

Diabetes mellitus (DM) is a micro-angiopathic disease that has been associated with decreased arterial and venous retinal blood flow velocities (RBFV). This study investigates the use of a novel non-contrast angiographic imaging device, the Retinal Functional Imager (RFI), to measure RBFV in patients with both non-proliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR).

 
Methods:
 

Prospective, cross-sectional study. The RFI device was used to quantitatively measure peri-foveal blood flow velocities in patients with NPDR and PDR. Control data was extrapolated from a recently published study using the same device.

 
Results:
 

The study included patients with NPDR (n=10, 20 eyes) and PDR (n=10, 20 eyes). The mean age was 58 ± 9.3 years, 45% were male, 55% were non-insulin dependent. 45% of eyes had clinically significant macular edema (CSME). Mean duration of DM diagnosis was 12.3 years. Mean arterial RBFV (mm/sec) were 4.19 ± 0.99 (Control), 3.83 ± 0.53 (NPDR), and 3.36 ± 0.33 (PDR). The mean venous velocities were 3.03 ± 0.59 (Control), 2.78 ± 0.55 (NPDR), and 2.43 ± 0.35 (PDR). Compared to control eyes, PDR eyes had a lower arterial (p<.001) and venous (p<.001) velocities. When compared to NPDR eyes, PDR eyes had a lower arterial (p<.001) and venous (p<.05) velocities. Pearson's correlation coefficient analysis showed that RBFV were not closely correlated with age, gender, visual acuity, insulin use, presence of CSME, years of DM diagnosis, or history of pan-retinal or focal laser.

 
Conclusions:
 

Eyes with PDR were shown to have a slower peri-foveal retinal arterial and venous blood velocities compared to healthy controls and NPDR.Figure 1: RFI image with peri-foveal arterial (red) and venous (purple) velocities (mm/sec) in diabetic retinopathy.  

 
Keywords: imaging/image analysis: clinical • diabetic retinopathy • blood supply 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×